DuPont uvedl na trh chromatografické médium AmberChrom SIL určené k čištění peptidových léčiv, včetně terapií GLP-1. Je dostupné v chemických variantách C8 a C18.
Key Takeaways DuPont launches AmberChrom SIL silica gel to enhance peptide purification, including GLP-1 therapeutics.Available in C8 and C18 chemistries, the new media offers high resolution, stability and scalability.DuPont's new media integrates with existing chromatography resins to optimize purity, yield and recovery.
DuPont de Nemours, Inc. (DD - Free Report) has launched AmberChrom SIL silica gel, a new reverse-phase silica-based chromatography media designed to support the purification and manufacturing of peptide therapeutics, including glucagon-like peptide-1 (GLP-1) receptor agonists. The launch expands DuPont’s bioprocessing purification portfolio and strengthens its suitability for high-purity polishing.
Growing demand for peptide therapeutics for the treatment of diabetes, obesity and other chronic conditions is increasing the need for efficient purification technologies at a larger scale. AmberChrom SIL silica gel is designed to help biopharmaceutical manufacturers meet stringent purity requirements while maintaining high yields.
Available in C8 and C18 chemistries, the new product offers high resolution, stability and scalability for demanding peptide separations. It can be used during multiple stages of purification to address diverse impurity profiles and specific process requirements.
DuPont’s latest launch can also be integrated with its existing chromatography technologies, including AmberChrom XT, AmberChrom TQ1 and CG resins. Combining silica-based and polymeric chromatography technologies with a single purification workflow enables manufacturers to optimize purity, yield and recovery across multiple stages.
The launch reinforces DuPont’s focus on expanding its solutions to address evolving needs by offering process development and manufacturing scale-up to optimize purification workflows and achieve purity targets.
Shares of DD have lost 44.4% over the past year against the 1.2% rise of its industry.
Better-ranked stocks in the Basic Materials space are Reliance, Inc. (RS - Free Report) , Cabot Corporation (CBT - Free Report) and Avient Corporation (AVNT - Free Report) .
RS currently sports a Zacks Rank #1 (Strong Buy), while CBT and AVNT carry a Zacks Rank #2 (Buy) each. You can see the complete list of today’s Zacks #1 Rank stocks here
The Zacks Consensus Estimate for RS’ 2026 earnings is pegged at $23.70 per share, indicating a 66.2% year-over-year surge. RSshares have gained 50.8% over the past year.
The Zacks Consensus Estimate for CBT’s current fiscal-year earnings is pinned at $6.35 per share. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters, with an average surprise of 4.56%. CBTshares have gained 4.2% over the past year.
The Zacks Consensus Estimate for AVNT’s 2026 earnings is pegged at $3.2 per share, indicating a year-over-year rise of 13.48%. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 3.4%.
Krilogy Financial LLC lifted its position in shares of DuPont de Nemours, Inc. (NYSE:DD – Free Report) by 615.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 23,638 shares of the basic materials company’s stock after purchasing an additional 20,333 shares during the period. Krilogy Financial LLC’s holdings in DuPont de Nemours were worth $3,070,000 at the end of the most recent quarter.
Other large investors also recently made changes to their positions in the company. Nalls Sherbakoff Group LLC bought a new stake in DuPont de Nemours in the 4th quarter worth about $29,000. Elevation Wealth Partners LLC lifted its position in shares of DuPont de Nemours by 168.5% during the 2nd quarter. Elevation Wealth Partners LLC now owns 239 shares of the basic materials company’s stock worth $32,000 after buying an additional 150 shares in the last quarter. Bangor Savings Bank bought a new position in shares of DuPont de Nemours during the 3rd quarter worth approximately $36,000. Grove Bank & Trust bought a new position in shares of DuPont de Nemours during the 3rd quarter worth approximately $40,000. Finally, Coastline Trust Co purchased a new position in shares of DuPont de Nemours in the 3rd quarter worth approximately $44,000. 73.96% of the stock is owned by institutional investors.
DuPont de Nemours Trading Down 0.9% Shares of DD stock opened at $128.41 on Thursday. The company’s fifty day simple moving average is $133.78 and its two-hundred day simple moving average is $138.29. The company has a debt-to-equity ratio of 0.23, a current ratio of 2.43 and a quick ratio of 1.82. DuPont de Nemours, Inc. has a 1 year low of $97.34 and a 1 year high of $157.98. The stock has a market capitalization of $17.34 billion, a price-to-earnings ratio of 285.42, a PEG ratio of 1.18 and a beta of 1.05.
DuPont de Nemours (NYSE:DD – Get Free Report) last posted its earnings results on Tuesday, August 4th. The basic materials company reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.76 by $0.12. DuPont de Nemours had a return on equity of 6.92% and a net margin of 0.67%. The firm had revenue of $1.82 billion for the quarter, compared to the consensus estimate of $1.81 billion. During the same quarter in the prior year, the business posted $1.12 earnings per share. The business’s quarterly revenue was up 4.0% on a year-over-year basis. DuPont de Nemours has set its Q3 2026 guidance at 1.800-1.900 EPS. As a group, analysts anticipate that DuPont de Nemours, Inc. will post 7.26 earnings per share for the current year. DuPont de Nemours Announces Dividend The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 15th. Investors of record on Monday, November 30th will be issued a dividend of $0.60 per share. The ex-dividend date of this dividend is Monday, November 30th. This represents a $2.40 dividend on an annualized basis and a yield of 1.9%. DuPont de Nemours’s dividend payout ratio is 533.33%.
Wall Street Analysts Forecast Growth A number of equities analysts have recently weighed in on DD shares. The Goldman Sachs Group cut their target price on DuPont de Nemours from $159.00 to $153.00 and set a “neutral” rating on the stock in a research note on Wednesday, September 30th. JPMorgan Chase & Co. downgraded DuPont de Nemours from an “overweight” rating to a “neutral” rating and decreased their price target for the company from $172.00 to $145.00 in a research report on Friday, October 9th. Zacks Research lowered DuPont de Nemours from a “strong-buy” rating to a “hold” rating in a report on Friday, July 17th. Royal Bank Of Canada dropped their price target on DuPont de Nemours from $180.00 to $176.00 and set an “outperform” rating on the stock in a report on Friday, August 7th. Finally, UBS Group cut their price objective on DuPont de Nemours from $178.00 to $172.00 and set a “buy” rating on the stock in a research report on Monday, October 5th. Twelve analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $163.00.
View Our Latest Research Report on DuPont de Nemours
DuPont de Nemours Company Profile (Free Report)
DuPont de Nemours, Inc is a science and technology company that develops engineered materials, specialty chemicals and other performance solutions for industrial and consumer markets. Its products are used in areas including electronics and semiconductor manufacturing, water purification, healthcare, transportation, construction, aerospace, worker safety and industrial processing.
DuPont’s portfolio includes well-known brands and materials such as Kevlar aramid fiber, Nomex flame-resistant materials, Tyvek protective materials, Kapton polyimide film, Vespel high-performance parts and Corian solid-surface materials.
Featured Articles Five stocks we like better than DuPont de Nemours Tesla Wants to Make Its Own Chips—What Could Go Wrong? IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver? PBF Energy’s Stunning Rally Faces a Critical Test Citi Stock Falls Despite Earnings Beat: What Investors Need to Know Want to see what other hedge funds are holding DD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DuPont de Nemours, Inc. (NYSE:DD – Free Report).
Receive News & Ratings for DuPont de Nemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DuPont de Nemours and related companies with MarketBeat.com's FREE daily email newsletter.
DuPont spustil digitální nástroj Sugar Separation Advisor, který pomáhá výrobcům cukru a sladidel vyhodnocovat chromatografické separace a navrhuje vhodné pryskyřice AmberLite k testování.
Key Takeaways DuPont launched a digital tool to help sugar and sweetener makers evaluate chromatographic separation options.The Sugar Separation Advisor predicts chromatograms and suggests AmberLite resins for further testing.DuPont raised its 2026 guidance after Q2 outperformance, citing stronger EBITDA and adjusted earnings. DuPont de Nemours, Inc.(DD - Free Report) is strengthening its position in the specialty chemicals market with the launch of the DuPont Sugar Separation Advisor, an interactive digital tool designed to help sugar and sweetener manufacturers evaluate chromatographic separation opportunities and identify suitable DuPont AmberLite resins for further testing.
DuPont, which is among the prominent players in the chemical space alongside Dow Inc. (DOW - Free Report) , Eastman Chemical Company (EMN - Free Report) and Celanese Corporation (CE - Free Report) , is focusing on innovation, productivity and growth across healthcare, water and industrial markets. The company's latest digital initiative expands access to its chromatography expertise and experimental separation data, while its broader portfolio includes solutions for healthcare, industrial water, food and beverage and other industrial applications.
The DuPont Sugar Separation Advisor builds on decades of chromatography application expertise and years of experimental separation data. The tool enables users to select a target sugar or sweetener, add up to four additional sugars or impurities to represent their feed stream and generate a predicted chromatogram based on experimental separation data. It then provides a qualitative separation assessment and suggests candidate DuPont AmberLite chromatography resins for further evaluation.
According to DuPont, the platform is designed to simplify the early stages of separation evaluation by helping customers identify promising resin options and focus laboratory testing. This could support manufacturers evaluating applications ranging from high-fructose corn syrup and beet sugar processing to rare sugars, oligosaccharides, polysaccharides and sugar alcohols.
DuPont developed the tool in response to recurring customer questions involving sugars and sweeteners such as allulose, tagatose, sorbitol, oligosaccharides, xylose and inositol. The resource displays laboratory-generated separation data for relevant sugar and resin combinations, helping users assess resin performance in application-relevant scenarios.
DuPont, in August, raised the midpoint of its full-year 2026 operating EBITDA and adjusted earnings guidance following its second-quarter outperformance. The company now expects net sales of $7.16-$7.19 billion, operating EBITDA of $1.75-$1.77 billion and adjusted earnings of $7.17-$7.32 per share. For the second half of 2026, DD projects net sales of $3.66-$3.69 billion, operating EBITDA of $890-$910 million and adjusted earnings of $3.65-$3.80 per share.
Dow expects approximately $200 million in additional benefits from its Transform to Outperform program in 2026, taking total in-year benefits from self-help initiatives to more than $1.3 billion. In the second half, the company plans to focus on growth and innovation in attractive end markets, portfolio investments and balanced capital allocation. DOW expects productivity and growth benefits from the program to accelerate through the remainder of 2026 and into 2027.
EastmanChemical expects 2026 earnings to improve significantly from 2025. Operating cash flow is projected to approach $900 million. For the third quarter, adjusted earnings are expected to be near the second-quarter level of $1.97 per share. Advanced Materials is expected to benefit from improved price-cost dynamics and asset utilization, while Fibers should gain from higher acetate tow purchases.
Celanese expects third-quarter adjusted earnings of $1.35-$1.75 per share and continues to project 2026 adjusted earnings of approximately $6 per share. The company maintained its full-year free cash flow guidance of $700-$800 million. Growth initiatives, productivity measures and portfolio and footprint actions are expected to support 2026 performance and strengthen cash generation.
DuPont ve 2. čtvrtletí vykázal 4% organický růst tržeb díky působení ve zdravotnictví, water, aerospace a EV. Firma zároveň cílí na 90 mil. USD cenových opatření v roce 2026, aby kompenzovala vyšší náklady.
Key Takeaways DuPont's healthcare, water, aerospace and EV exposure supported 4% organic sales growth in Q2.Spectrum Plastics and Donatelle Plastics acquisitions strengthen DuPont's healthcare exposure and innovation.DuPont targets $90 million in 2026 pricing to offset higher input costs and limit margin pressure. DuPont de Nemours, Inc. (DD - Free Report) benefits from its innovation-driven investment, productivity actions and acquisitions amid uneven construction demand and persistent cost pressure.
DD’s shares are down 45.6% in the past year compared to the Zacks Chemicals Diversified industry’s 3.3% decline.
Image Source: Zacks Investment Research
Let’s find out why DD stock is worth retaining at the moment.
Productivity, Innovation & Acquisitions Aid DD StockDuPont remains focused on organic growth through innovation, commercial execution and targeted acquisitions. Its innovation-driven investment is focused on several high-growth areas. DD's portfolio is exposed to healthcare, water, aerospace and electric vehicle (EV) applications, which supported 4% organic sales growth in second-quarter 2026. The company is expanding its innovation pipeline through direct lithium extraction solutions in Water, Liveo products for biopharma and new solutions for electric vehicles and battery energy storage.
The acquisition of Spectrum Plastics Group, a leading manufacturer of specialty medical devices and components, strengthened DuPont’s position in stable and fast-growing healthcare end markets. It is also in sync with its focus on high-growth, customer-driven innovation for the healthcare market. The buyout of Donatelle Plastics also enhances DD’s exposure in healthcare, expanding its expertise in the medical device market segments.
DD said in August 2026 that it still had more than $1 billion available for potential mergers and acquisitions and was evaluating opportunities in water and healthcare. It also indicated that prospective acquisitions should add to the company’s growth algorithm and meet disciplined return thresholds. These actions support a more focused portfolio while retaining flexibility for selective growth investments and shareholder returns.
DuPont is also benefiting from cost synergy savings and productivity improvement actions. Its operating system is producing measurable cost and execution gains. In second-quarter 2026, net productivity improved and contributed to operating leverage. Management is targeting net productivity equal to 3% of cost of goods sold and expects to reach that run rate within about 18 months from August 2026. The 80/20 program is also moving from pilot work to implementation across four Diversified Industrials businesses, with a few million dollars of EBITDA benefit expected in second-half 2026. Full-year 2026 operating EBITDA guidance of $1.75-$1.77 billion implies continued benefits from organic growth and productivity.
Construction and Cost Headwinds Weigh On DuPontDuPont’s Building Technologies business remains exposed to a mixed construction backdrop. Organic sales rose in the low single digits in the second quarter as residential and non-residential demand improved, led by Asia Pacific, but management said single-family housing remained soft.
DD expects Building Technologies sales to increase only slightly for full-year 2026, indicating that the broader recovery remains limited. The company also noted that residential performance was above its underlying market in second-quarter 2026, which may make sustained growth more dependent on favorable market mix and end-market stabilization. This leaves Diversified Industrials exposed to uneven construction conditions even as aerospace and EV applications provide offsets.
Higher oil and gas-related input costs remain a margin drag in 2026 even though DuPont expects pricing to offset the dollar impact. Management said about $90 million of pricing is planned for full-year 2026, with most of it in the second half. Price-cost dynamics reduced second-quarter 2026 operating EBITDA margin by 30 basis points. The company expects a 50-basis-point margin drag in second-half 2026 and a 30-basis-point drag for the full year.
DD’s Zacks Rank & Other Key PicksDD currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Basic Materials space are Reliance, Inc. (RS - Free Report) , Innospec Inc. (IOSP - Free Report) and Avient Corporation (AVNT - Free Report) .
While RS currently sports a Zacks Rank #1 (Strong Buy), IOSP and AVNT carry a Zacks Rank #2 (Buy) each. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for RS’ 2026 earnings is pegged at $22.53 per share, indicating a 58% year-over-year increase. The consensus estimate for RS’s 2026 earnings has moved up 30.8% over the past 60 days.
The Zacks Consensus Estimate for IOSP’s current-year earnings is pegged at $5.03 per share, implying a 4.55% year-over-year decrease. Its earnings beat the Zacks Consensus Estimate in all of the trailing four quarters, with the average surprise being 12.9%.
The Zacks Consensus Estimate for AVNT’s current-year earnings is pinned at $3.2 per share, indicating a 13.48% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 3.4%.
Federální soudce v Connecticutu rozhodl, že více než 20 žalovaných včetně 3M, DuPont a Honeywell musí čelit žalobě hasičů kvůli kontaminaci ochranné výstroje „věčnými chemikáliemi“ PFAS.
Item 1 of 2 The logo of 3M is seen at the 3M Tilloy plant in Tilloy-Lez-Cambrai, France, August 18, 2019. REUTERS/Pascal Rossignol
[1/2]The logo of 3M is seen at the 3M Tilloy plant in Tilloy-Lez-Cambrai, France, August 18, 2019. REUTERS/Pascal Rossignol Purchase Licensing Rights, opens new tab
CompaniesSept 15 (Reuters) - A federal judge on Tuesday said more than 20 defendants including 3M (MMM.N), opens new tab, DuPont (DD.N), opens new tab and Honeywell (HON.O), opens new tab must face claims by Connecticut firefighters who said their protective gear was contaminated by toxic "forever chemicals" that increased their risk of cancer.
Lawyers for 13 firefighter union organizations and 12 individual firefighters said "turnout gear" that shields against extreme heat and flames leached the chemicals through absorption into skin, ingestion and inhalation. They have called the proposed class action the first to exclusively target firefighter gear containing per- and polyfluoroalkyl substances, or PFAS.
Sign up here.
U.S. District Judge Alvin Thompson in Hartford, Connecticut, said the unions had "organizational" standing to seek damages, and firefighters could seek damages and medical monitoring even if they had no outward symptoms of cancer and other diseases.
The judge also said the plaintiffs sufficiently alleged that 3M, one of the largest manufacturers of PFAS, owed a duty to warn about the risks and committed negligence.
PFAS in firefighters' protective gear included 3M's Scotchlite reflective material and DuPont's Kevlar, while Honeywell manufactured turnout gear, according to the complaint. Some DuPont liabilities now belong to two spinoffs, Chemours (CC.N), opens new tab and Corteva (CTVA.N), opens new tab.
Lawyers for 3M, DuPont, Chemours, Corteva and Honeywell did not immediately respond to requests for comment. Jennifer Sclar, a lawyer for the plaintiffs, said the decision was significant because it found that prolonged exposure to PFAS from turnout gear justified legal standing.
PFAS WIDELY USEDIn seeking dismissals, 3M said there were no plausible claims tying Scotchlite to firefighters' gear, while other defendants said there was no allegation that the gear "failed to serve its function of protecting firefighters from the hazards of fighting fires."
The lawsuit began in June 2024.
PFAS are found in hundreds of consumer and commercial products including cosmetics, non-stick pans and stain-resistant clothing.
They are known as "forever chemicals" because they do not break down easily in the human body or environment. PFAS have also been linked to higher cholesterol, low birth weight and reduced antibody response to vaccines.
In 2023, DuPont, 3M and two other companies reached more than $11 billion in settlements to resolve claims that firefighting foam and other products containing their PFAS polluted drinking water. None admitted wrongdoing.
Reporting by Jonathan Stempel in New York; Editing by Bill Berkrot
Our Standards: The Thomson Reuters Trust Principles., opens new tab
DuPontův systém MemCor MBR byl vybrán pro rozšíření čistírny odpadních vod v Canbeře a zvýší kapacitu o přibližně 97 milionů litrů denně. Zařízení se bude vyrábět v Austrálii.
Key Takeaways DuPont's MemCor MBR system was selected for a major wastewater treatment upgrade in Canberra.The system will provide about 97 million liters per day of treatment capacity and will be made in Australia.DuPont says rising population and infrastructure investment are driving demand for scalable water solutions. DuPont de Nemours, Inc. (DD - Free Report) recently announced that its MemCor membrane bioreactor (“MBR”) system has been selected for the expansion of the treatment facility at the Lower Molonglo Water Quality Control Center (“LMWQCC”) in Canberra, Australia. The project will help the facility address rising wastewater treatment demand driven by population growth.
The LMWQCC, owned and operated by Icon Water, is the largest inland wastewater treatment facility in Australia and has been operational since the late 1970s. As part of its major upgrade in collaboration with Seymour Whyte and VINCI Construction Grands Projects, the facility will add a new secondary treatment process based on advanced membrane technology.
DuPont’s MemCor MBR system will provide a treatment capacity of approximately 97 million liters per day, enabling the facility to support Canberra’s requirements. The system will also be manufactured in Australia, highlighting DuPont’s ability to combine global technology with local expertise.
The selection strengthens DuPont’s position in the market, where demand for efficient and scalable solutions is increasing alongside population growth and infrastructure investment. MemCor MBR systems, along with MemPulse modules, have been deployed across hundreds of municipal and industrial installations worldwide, building a high reputation based on high reliability.
DuPont’s Water Solutions portfolio includes membranes, resins and complete treatment systems serving municipalities, desalination plants and industrial users across 112 countries. The project further demonstrates the company’s role in addressing growing global water-treatment needs.
DD’s shares have lost 33.4% over the past year against the industry’s 7.4% rise.
Image Source: Zacks Investment Research
DD’s Zacks Rank & Key PicksDD currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Basic Materials space are Neo Performance Materials Inc. (NOPMF - Free Report) , Carpenter Technology Corporation (CRS - Free Report) and Avient Corporation (AVNT - Free Report) .
While NOPMF currently sports a Zacks Rank #1 (Strong Buy), CRS and AVNT carry a Zacks Rank #2 (Buy) each. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for NOPMF’s 2026 earnings is pinned at $1.48 per share, indicating a 202.04% year-over-year increase. NOPMF’s shares have gained 113.7% over the past year.
The Zacks Consensus Estimate for CRS’ fiscal 2027 earnings is pegged at $12.92 per share, indicating a rise of 20.07% year over year. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 8.39%.
The Zacks Consensus Estimate for AVNT’s current-year earnings is pinned at $3.17 per share, indicating a 12.41% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 3.4%. AVNT’s shares have gained 29.5% over the past year.
DuPont zvýšil celoroční odhad upraveného EPS na 7,24 USD a čeká ve druhé polovině asi 6% organický růst. Společnost zároveň plánuje zpětný odkup akcií za 250 milionů USD ve třetím čtvrtletí.
Key Takeaways DuPont raised adjusted EPS guidance to $7.24 and sees second-half organic growth of about 6%.Pricing and productivity are expected to support roughly 40% second-half incremental margins.DuPont plans a $250 million buyback and has well over $1 billion available for acquisitions. DuPont de Nemours, Inc. (DD - Free Report) used its second-quarter 2026 earnings call to raise its full-year outlook and outline a stronger second half. Adjusted earnings of $1.88 per share topped the Zacks Consensus Estimate of $1.76. Revenues of $1.819 billion marginally beat the consensus mark of $1.818 billion.
The call centered on execution, with management linking growth and margins to pricing, productivity, commercial improvements and 80/20 simplification.
DD Raises Its 2026 OutlookCFO Antonella Franzen raised the midpoint of full-year adjusted earnings guidance to $7.24 per share and operating EBITDA guidance to $1.76 billion. Organic sales growth is now expected to be slightly above 4%.
For the second half, Franzen projected about 6% organic growth, supported by healthcare, industrial water, aerospace and implemented pricing. She expects roughly 40% incremental margins after adjusting for price-cost effects.
The outlook assumes $90 million of pricing to remain price-cost neutral, while oil-and-gas inflation creates a 50-basis-point second-half margin headwind.
Third-quarter guidance calls for $1.835 billion in sales, $448 million in operating EBITDA and adjusted earnings of $1.80 to $1.90 per share. Currency is expected to reduce growth by about one percentage point.
DuPont Connects Growth and ExecutionCEO Lori Koch described one operating system linking innovation, commercial excellence, operational excellence and 80/20. DuPont is using it to prioritize higher-value opportunities and scale successful practices.
Koch said that the innovation vitality index is about 35%, with greater emphasis shifting toward growth products. Launches include direct lithium extraction solutions, expanded biopharma offerings and products for electric vehicles and battery storage.
A Morgan Stanley analyst asked about AI-enabled selling. Koch said AI cut sales-play preparation to four weeks, while the commercial organization drove a roughly 30% win rate and $5 million to $6 million in incremental garment sales.
DD Sees Water Timing, Not Structural WeaknessGoldman Sachs and Mizuho analysts focused on Middle East water-project delays. Koch said that projects remain booked but have shifted, with more revenues expected in the fourth quarter than the third.
Water organic sales grew at a low-single-digit rate, but increased at a mid-single-digit pace outside the Middle East. Koch said that the region represents about 10% of Water sales.
DuPont now expects low-to-mid-single-digit Water growth for 2026 and high-single-digit growth in the second half. Stronger Healthcare demand is offsetting the revision and preserving the segment’s overall growth profile.
DuPont Sets Higher Productivity GoalsA Melius Research analyst asked how quickly DuPont can reach its productivity target. Koch aims to reduce cost of goods sold by 3% annually on a net basis, with that run rate achievable within 18 months.
The quarter delivered about 200 basis points of COGS reduction, contributing roughly 100 basis points to margin expansion. Koch also put cost of poor quality near 4% of sales, below a benchmark of about 5%.
The 80/20 program should add a few million dollars of EBITDA in the second half through simplification, yield improvement and better resource allocation. Koch said it should not create a material top-line headwind.
DD Pairs Buybacks With M&A CapacityDuPont plans a $250 million third-quarter share repurchase after transaction-adjusted free cash flow conversion reached 127% in the quarter.
Franzen said full-year conversion should finish much closer to 100% than the prior 90% target. Improvements in receivables, payables and inventory supported the cash result.
A Wolfe Research analyst asked about acquisitions. Koch said that DuPont has well over $1 billion available and is evaluating Water and Healthcare targets, including packaging and contract development and manufacturing opportunities, while maintaining return discipline.
DuPont Stays Focused on Repeatable ExecutionKoch’s message was that growth initiatives, productivity and portfolio focus are becoming repeatable operating disciplines. Franzen paired that posture with higher guidance and continued underlying margin momentum.
The second-half plan still depends on pricing realization, project timing and strength in healthcare, industrial water and aerospace. Management remained confident while acknowledging those execution requirements.
What DD’s Zacks Signals SayDD carries a Zacks Rank #3 (Hold) at present. Its Momentum Score of A indicates favorable momentum characteristics, but the Value Score of D, Growth Score of F and VGM Score of F show weaker readings across valuation, growth and the combined style profile. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Style Score complements the Zacks Rank, with A and B scores preferred. DD’s mix presents a neutral and uneven near-term signal, and the Zacks Rank can change as analysts revise earnings estimates following the reported results.
DuPont de Nemours vykázal za čtvrtletí končící v červnu 2026 tržby 1,82 mld. USD, meziročně o 44,2 % méně. Zisk na akcii činil 1,88 USD oproti 3,36 USD loni.
For the quarter ended June 2026, DuPont de Nemours (DD - Free Report) reported revenue of $1.82 billion, down 44.2% over the same period last year. EPS came in at $1.88, compared to $3.36 in the year-ago quarter.
The reported revenue represents a surprise of +0.06% over the Zacks Consensus Estimate of $1.82 billion. With the consensus EPS estimate being $1.76, the EPS surprise was +6.82%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how DuPont de Nemours performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Change in Net Sales - Healthcare & Water Technologies - Currency: 1% versus 0.3% estimated by two analysts on average.Change in Net Sales - Diversified Industrials - Total: 3% versus the two-analyst average estimate of 1.7%.Change in Net Sales - Healthcare & Water Technologies - Total: 5% versus 5.3% estimated by two analysts on average.Net sales- Diversified Industrials: $963 million versus the two-analyst average estimate of $946.87 million.Net sales- Healthcare & Water Technologies: $856 million compared to the $859.9 million average estimate based on two analysts.Operating EBITDA- Healthcare & Water Technologies: $258 million versus the two-analyst average estimate of $256.59 million.Operating EBITDA- Corporate: $-23 million compared to the $-31.56 million average estimate based on two analysts.Operating EBITDA- Diversified Industrials: $213 million versus the two-analyst average estimate of $205.21 million.View all Key Company Metrics for DuPont de Nemours here>>>
Shares of DuPont de Nemours have returned +0.2% over the past month versus the Zacks S&P 500 composite's +1.7% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
DuPont ve 2. čtvrtletí překonal odhady zisku i tržeb, když organické tržby vzrostly o 4 %. Firma zároveň zvýšila střed letošního výhledu pro EBITDA a upravený EPS.
Key Takeaways DD beat Q2 earnings and sales estimates as organic sales rose 4% on broad-based end-market strength.DD raised the midpoint of full-year guidance for EBITDA and adjusted EPS after Q2 outperformance.DD generated stronger operating cash flow and free cash flow, supported by higher earnings. DuPont de Nemours, Inc. (DD - Free Report) reported second-quarter 2026 net income from continuing operations of $191 million or $1.37 per share, up sharply from $24 million or 17 cents per share in the year-ago quarter.
Barring one-time items, adjusted earnings came in at $1.88 per share, up from the year-ago quarter’s $1.27. The figure beat the Zacks Consensus Estimate of $1.76.
Net sales of $1,819 million increased 4% year over year and marginally topped the Zacks Consensus Estimate of $1,817.9 million. Organic sales also improved 4%, driven by continued strength across healthcare, industrial water and aerospace end markets.
DuPont de Nemours, Inc. Price, Consensus and EPS SurpriseDD’s Segment HighlightsHealthcare & Water Technologies generated net sales of $856 million, up 5% year over year. It missed the Zacks Consensus Estimate of $860 million. Organic sales rose 4%, while currency contributed 1%. Healthcare Technologies recorded mid-single-digit organic growth on broad-based increase led by personal protection and biopharma, while Water Technologies posted low-single-digit organic growth driven by industrial water and semiconductor markets, partly offset by weakness in the Middle East. Operating EBITDA increased 4% to $258 million.
Diversified Industrials recorded net sales of $963 million, up 3% year over year, exceeding the Zacks Consensus Estimate of $947 million. Organic sales increased 3%, supported by growth in Building Technologies from residential and non-residential construction markets and continued aerospace and electric vehicle strength in Industrial Technologies. Operating EBITDA improved 7% year over year to $213 million.
DD’s FinancialsDuPont ended the quarter with cash and cash equivalents of $1.74 billion, up significantly from $715 million at the end of 2025. Long-term debt was $3.13 billion, essentially flat with year-end 2025.
Cash provided by operating activities from continuing operations totaled $400 million in the quarter compared with $74 million in the year-ago period. Transaction-adjusted free cash flow rose to $326 million from $107 million a year ago, reflecting stronger earnings and improved cash conversion.
DD’s OutlookFollowing its second-quarter outperformance, DuPont raised the midpoint of its full-year 2026 operating EBITDA and adjusted earnings guidance. The company now expects net sales in the range of $7.16-$7.19 billion, operating EBITDA between $1.75 billion and $1.77 billion and adjusted earnings of $7.17-$7.32 per share.
For the second half of 2026, DuPont projects net sales of $3.66-$3.69 billion, operating EBITDA of $890-$910 million and adjusted earnings of $3.65-$3.80 per share. Management also expects organic sales growth to be slightly above 4% for the full year.
The outlook reflects continued strength across healthcare, industrial water and aerospace end markets. Management expects mid-single-digit organic sales growth in the second half and remains focused on productivity, profitable growth and shareholder value creation.
DD’s Price Performance DD's shares are down 35.1% in the past year compared with the Zacks Chemicals Diversified industry’s 3.9% rise.
Image Source: Zacks Investment Research
DD’s Zacks Rank & Key PicksDD currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Basic Materials space are Avient Corporation (AVNT - Free Report) , Neo Performance Materials Inc. (NOPMF - Free Report) and Lundin Mining Corporation (LUNMF - Free Report) .
Avient is scheduled to report second-quarter results on Aug. 6. The Zacks Consensus Estimate for AVNT’s second-quarter earnings is pegged at 89 cents per share. It carries a Zacks Rank #2 (Buy) at present.
NOPMF is slated to report second-quarter results on Aug. 11. The Zacks Consensus Estimate for earnings is pegged at 5 cents per share. NOPMF has a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Lundin Mining is scheduled to report second-quarter results on Aug. 5. The Zacks Consensus Estimate for LUNMF’s second-quarter earnings is pegged at 34 cents per share. It currently carries a Zacks Rank #2.
DuPont oznámí výsledky za 2. čtvrtletí 4. srpna; trh čeká tržby 1 817,9 milionu USD, tedy meziroční pokles o 44,2 %. Firma čelí slabé poptávce v segmentu stavebnictví a vyšším nákladům.
Key Takeaways DuPont reports Q2 results on Aug. 4 after beating earnings estimates in each of the last four quarters.DD is expected to benefit from innovation, acquisitions and productivity actions despite inflation pressures.DuPont faces soft construction demand and cost headwinds that may weigh on its Q2 performance. DuPont de Nemours, Inc. (DD - Free Report) is set to release second-quarter 2026 results before the opening bell on Aug. 4.
The company beat the Zacks Consensus Estimate for earnings in each of the last four quarters. It has a trailing four-quarter earnings surprise of 8% on average. DuPont is expected to have benefited from its innovation-driven investment, productivity actions and acquisitions amid headwinds from cost inflation in the second quarter.
DD’s shares have lost 35.1% in a year, underperforming the Zacks Chemicals Diversified industry’s 0.5% rise.
Image Source: Zacks Investment Research
Let’s see how things are shaping up for this announcement.
What do DD’s Revenue Estimates Indicate?The Zacks Consensus Estimate for DD’s second-quarter consolidated sales is currently pegged at $1,817.9 million, calling for a decline of 44.2% from the year-ago quarter’s tally.
The consensus estimate for the company’s Healthcare & Water Technologies segment is pinned at $860 million. The same for the Diversified Industrials unit is pegged at $947 million.
Factors at Play for DD StockDuPont is likely to have benefited from its cost and productivity measures, acquisitions and actions to drive growth through innovation in the quarter to be reported. Its innovation-driven investment is focused on several high-growth areas. DD remains committed to driving returns from its R&D investment.
The acquisition of Spectrum Plastics Group, a leading manufacturer of specialty medical devices and components, strengthened DuPont’s position in stable and fast-growing healthcare end markets. It is also in sync with its focus on high-growth, customer-driven innovation for the healthcare market. The buyout of Donatelle Plastics also enhances DD’s exposure in healthcare, expanding its expertise in the medical device market segments.
DuPont is expected to have benefited from cost synergy savings and productivity improvement actions in the June quarter. These actions contributed to a 100-basis-point year-over-year growth in operating margins in 2025. The additional benefits of its structural cost actions are expected to be realized in 2026. The company also continues to implement strategic price increases in the wake of raw material and energy cost inflation. Its cost and productivity actions, along with pricing measures, are expected to have contributed to its margins in the to-be-reported quarter.
DD is expected to have faced continued headwinds in the construction markets. In North America, uncertainties surrounding the U.S. housing market are weighing on construction. Elevated borrowing costs and inflation have unfavorably impacted the residential construction industry. The weakness in construction and automotive markets is likely to have affected second-quarter sales in the diversified industrials business. The softness in the automotive market is due to weak automotive build rates across the United States and Europe.
DuPont is also exposed to challenges from cost inflation and logistics disruptions due to the Middle East conflict. The company faces challenges from higher raw material costs resulting from the conflict. While it is taking pricing actions to offset the incremental costs, the impacts of cost inflation are expected to reflect on its performance. Higher input costs are likely to have weighed on its margins in the second quarter.
What Our Model Unveils for DD StockOur proven model does not conclusively predict an earnings beat for DuPont this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. But that’s not the case here.
Earnings ESP: Earnings ESP for DD is -0.33%. The Zacks Consensus Estimate for the second quarter is currently pegged at $1.76. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: DD currently carries a Zacks Rank #3.
Basic Materials Stocks That Warrant a LookHere are some companies in the basic materials space you may want to consider as our model shows they have the right combination of elements to post an earnings beat this quarter:
Avient Corporation (AVNT - Free Report) , scheduled to release earnings on Aug. 6, has an Earnings ESP of +0.87% and carries a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
The consensus estimate for AVNT’s earnings for the second quarter is currently pegged at 89 cents.
The Chemours Company (CC - Free Report) , scheduled to release earnings on Aug. 4, has an Earnings ESP of +27.17%.
The Zacks Consensus Estimate for CC's earnings for the second quarter is currently pegged at 43 cents. CC currently sports a Zacks Rank #1.
Minerals Technologies Inc. (MTX - Free Report) , slated to release earnings on July 30, has an Earnings ESP of +0.61% and carries a Zacks Rank #2 at present.
The consensus mark for MTX’s second-quarter earnings is currently pegged at $1.64.
DuPont spustil více než 20 produktové end-to-end portfolio pro přímou extrakci lithia z solanek. Cílí na vyšší výtěžnost a přizpůsobení různým složením solanek.
Tailored direct lithium extraction solutions combine advanced sorbents, membranes, ion exchange resins, and technical expertise to enable high-performance lithium recovery across diverse brine compositions
, /PRNewswire/ -- DuPont (NYSE: DD) today announced it has launched an end-to-end Direct Lithium Extraction (DLE) portfolio comprising more than 20 products across multiple technologies, designed to improve lithium recovery and provide tailored solutions for diverse brine resources, supporting scalable lithium production amid accelerating global demand. As an alternative to traditional lithium processing approaches such as hard rock mining or evaporation, DLE is well positioned to support growing lithium demand through advanced separation technologies designed to extract lithium effectively and efficiently from brine.
The new DLE portfolio spans lithium-selective sorbents, nanofiltration and reverse osmosis membranes, and ion exchange resins across the entire lithium brine treatment process, from extraction and purification to final concentration. This integrated flowsheet design enables customers to implement end-to-end solutions or select individual technologies tailored to their specific process requirements and brine compositions.
A key differentiator of DuPont's new portfolio is its breadth and flexibility, which allows DuPont to design customized solutions across a wide range of lithium extraction applications. For example, the portfolio includes specialized lithium-selective DuPont™ AmberSorb™ adsorbent technologies for both high- and low-temperature brine streams to meet the needs for efficient lithium recovery from diverse global resources. In addition, DuPont provides different grades of FilmTec™ LiNE nanofiltration and reverse osmosis elements, offering unique separation characteristics and incorporation of low salt rejection reverse osmosis (LSRRO) technology to achieve ultra-high lithium concentration.
These capabilities are enhanced by advanced DuPont™ IntegraTec™ and Inge™ ultrafiltration modules, FilmTec™ nanofiltration and reverse osmosis membranes, and DuPont™ AmberLite™ ion exchange resins, which improve lithium yield, purity, and concentration throughout the process. By bringing these technologies together into a single, cohesive platform, DuPont enables customers to optimize performance and recovery across the full direct lithium extraction flowsheet.
"DLE processes are highly sensitive to the lithium brine composition, temperature, and competing ions. By integrating the lithium-selective sorbents, membranes, and ion exchange technologies into a single process design framework, we can optimize the full flowsheet rather than treating them in isolation," said Dr. Martin Deetz, Senior R&D Laureate for DuPont Water Solutions. "Our customers are trying to move from the lab to reliable lithium production as quickly as possible. By combining these technologies with advanced modeling, testing, and piloting support, we can help accelerate the design of tailored, end-to-end lithium extraction flowsheets for their specific brine resources and goals."
DuPont further supports customers through its global research and development network, offering advanced laboratory testing and process modeling. These services allow lithium producers to validate performance using real brine samples and accelerate process development. This approach positions DuPont as a technical collaborator, helping customers move from initial evaluation to implementation with greater speed, confidence, and process reliability. As demand for lithium surges to power electric vehicles and energy storage systems, the industry is increasingly adopting DLE as a more coordinated and efficient approach to unlocking new lithium resources.
DuPont's technical experts hosted an educational webinar on June 18, 2026 to help customers understand how tailored DLE technologies can increase lithium yield and purity while addressing the unique characteristics of their brine resources. The session highlighted how customers can leverage DuPont's testing, modeling, and piloting support to evaluate and implement customized solutions. Watch on-demand here: https://www.dupont.com/water/contact-us.html?dfp=water-webinar-direct-lithium-extraction&src=ws_global_newsletter_dlewebinar_website_pressrelease_2026-07-14
Learn more about DuPont's Direct Lithium Extraction portfolio at https://www.dupont.com/water/applications/direct-lithium-extraction-solutions.html.
About DuPont
DuPont (NYSE: DD) is a global innovation leader, providing advanced solutions that help transform industries and improve everyday life across our key markets of healthcare, water, construction, and industrial. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.
DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, ℠ or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted.
DuPont oznámil čtvrtletní dividendu ve výši 0,60 USD na akcii kmenových akcií. Splatná bude 15. září 2026 akcionářům, kteří budou držiteli akcií k 31. srpnu 2026.
Resources Investor Relations Journalists Agencies Client Login Send a Release
News Products Contact Hamburger menu Send a Release
WILMINGTON, Del., June 24, 2026 /PRNewswire/ -- DuPont (NYSE: DD) today announced that its Board of Directors has declared a quarterly dividend of sixty cents ($0.60) per share on the outstanding Common Stock of the Company (par value $0.01 per share) payable on September 15, 2026, to holders of record of said stock at the close of business on August 31, 2026.
About DuPont
DuPont (NYSE: DD) is a global innovation leader, providing advanced solutions that help transform industries and improve everyday life across our key markets of healthcare, water, construction, and industrial. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.
DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, SM or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted.
